Study: Cholesterol drug lowers risk of death, heart attack

Study: Cholesterol drug lowers risk of death, heart attack


This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It's one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can.



from Biotech News